House OKs PDUFA bill, sans DTC restrictions
The House has approved legislation that would reauthorize PDUFA and strengthen the FDAs hand, allowing it to require post-market drug safety studies and fine companies as much as $250,000 for airing false and misleading ads.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.